Photo of a scientist

04

Pipeline

Our DynamoTM platform and approach are creating new possibilities in drug discovery

Program

Discovery

IND Enabling

Phase 1

Phase 2

Phase 3

RLY-4008

FGFR2

RLY-2608

PI3Kα pan-mutant

RLY-1971

SHP2

Discovery Programs (5+)

While our initial focus has been on enhancing small molecule therapeutic discovery in precision oncology, protein conformational dynamics are implicated in a wide variety of therapeutic areas. We have also leveraged the power of our Dynamo platform to extend to genetic disease as well.

Current Discovery Programs

Our current discovery programs are focused in targeted oncology (3) and genetic disease (2).

Potential Future Therapeutic Areas

We also continue to evaluate potential additional therapeutic areas beyond precision oncology and genetic disease that we could enter in the future.

At Relay Therapeutics, we know that patients need new medicines now. This is the driving force behind everything we do.